<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Pathology Publications</title>
<copyright>Copyright (c) 2013 Western University All rights reserved.</copyright>
<link>http://ir.lib.uwo.ca/patholpub</link>
<description>Recent documents in Pathology Publications</description>
<language>en-us</language>
<lastBuildDate>Sun, 27 Jan 2013 00:41:24 PST</lastBuildDate>
<ttl>3600</ttl>








<item>
<title>Is There a Correlation between the Proportion of Cells with Isodicentric Yp at Amniocentesis and Phenotypic Sex?</title>
<link>http://ir.lib.uwo.ca/patholpub/8</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/patholpub/8</guid>
<pubDate>Sun, 29 Aug 2010 23:27:51 PDT</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVES: (1) To present a case with prenatally detected idic Yp. (2) To review literature to assess if there is a correlation between the proportion of amniocytes with idic Yp and phenotypic sex.</p>
<p>METHODS: Seventeen cases were reviewed.</p>
<p>RESULTS: Amniocentesis was done due to positive integrated prenatal screening result. Interphase FISH was normal for chromosomes 13, 18, and 21, but mosaic for cell lines with 1 X and 0 to 2 copies of DYZ3, SRY, or DYZ1(Yq12). Amniocytes had 45,X[28]/46,X,idic(Y)(q11.2)[2].ish idic(Y)(DYZ3 + +, SRY + +). An apparently normal female was born at 37 weeks. The umbilical cord had 45,X[50], but cord blood had 45,X[17]/46,X,idic(Y)[31]/47,X,idic(Y)x2[2]. Review of 17 cases showed that 13 cases with 20 to 100% cells with idic Yp all had a male phenotype. Two cases with 3 and 7% of idic Yp cells had a female phenotype. Two cases with 45,X only at prenatal diagnosis but idic Yp detected postnatally were phenotypic male.</p>
<p>CONCLUSION: (1) We present the first report of prenatally detected idic Yp and Yq12 resulting in an apparently normal female at birth. (2) Finding of > 20% of G-banded amniocytes with idic Yp in the absence of other indicators of foetal structural anomalies seems to correlate with phenotypically normal male in most cases.</p>

	]]>
</description>

<author>Jie Xu et al.</author>


</item>






<item>
<title>Invasive Lobular Carcinoma of the Breast Presenting as Retroperitoneal Fibrosis: A Case Report</title>
<link>http://ir.lib.uwo.ca/patholpub/7</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/patholpub/7</guid>
<pubDate>Mon, 16 Aug 2010 13:03:57 PDT</pubDate>
<description>
	<![CDATA[
	<p>INTRODUCTION: Invasive lobular carcinoma of the breast represents approximately 6.3% of mammary malignancies. Distant metastasis of invasive lobular carcinoma to the peritoneum or retroperitoneum has been reported fairly frequently.</p>
<p>CASE PRESENTATION: We report the case of a 59-year-old Caucasian-Canadian woman with invasive lobular carcinoma of the breast presenting with retroperitoneal fibrosis and bilateral ureteral obstruction. Intra-operative pathology consultation did not reveal malignancy. The diagnosis, however, was confirmed on permanent sections by histological appearance in addition to immunohistochemistry. To the best of our knowledge, this is the first reported case of invasive lobular carcinoma of the breast presenting with retroperitoneal fibrosis.</p>
<p>CONCLUSION: In a case of unexplained ureteric obstruction and retroperitoneal fibrosis, more comprehensive physical examination and additional ancillary studies may be warranted to rule out malignancy as an underlying etiology. This case also emphasizes that intra-operative frozen section consultation cannot always be fully relied upon to exclude a malignancy as the etiology of retroperitoneal fibrosis. Moreover, in permanent histopathology sections, immunohistochemistry testing can be of value to rule out metastatic disease where the morphology is not salient. There is a need for a thorough physical examination of patients with retroperitoneal fibrosis, including the breast and gynecological organs.</p>

	]]>
</description>

<author>George M. Yousef et al.</author>


</item>






<item>
<title>Human 21T Breast Epithelial Cell Lines Mimic Breast Cancer Progression in Vivo and in Vitro and Show Stage-specific Gene Expression Patterns</title>
<link>http://ir.lib.uwo.ca/patholpub/6</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/patholpub/6</guid>
<pubDate>Wed, 04 Aug 2010 22:41:42 PDT</pubDate>
<description>
	<![CDATA[
	<p>Early breast cancer progression involves advancement through specific morphological stages including atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and invasive mammary carcinoma (IMC), although not necessarily always in a linear fashion. Observational studies have examined genetic, epigenetic and gene expression differences in breast tissues representing these stages of progression, but model systems which would allow for experimental testing of specific factors influencing transition through these stages are scarce. The 21T series cell lines, all originally derived from the same patient with metastatic breast cancer, have been proposed to represent a mammary tumor progression series. We report here that three of the 21T cell lines indeed mimic specific stages of human breast cancer progression (21PT-derived cells, ADH; 21NT-derived cells, DCIS; 21MT-1 cells, IMC) when grown in the mammary fat pad of nude mice, albeit after a year. To develop a more rapid, readily manipulatable in vitro assay for examining the biological differences between these cell lines, we have used a 3D Matrigel system. When the three cell lines were grown in 3D Matrigel, they showed characteristic morphologies, in which quantifiable aspects of stage-specific in vivo behaviors (ie, differences in acinar structure formation, cell polarization, colony morphology, cell proliferation, cell invasion) were recapitulated in a reproducible fashion. Gene expression profiling revealed a characteristic pattern for each of the three cell lines. Interestingly, Wnt pathway alterations are particularly predominant in the early transition from 21PTci (ADH) to 21NTci (DCIS), whereas alterations in expression of genes associated with control of cell motility and invasion phenomena are more prominent in the later transition of 21NTci (DCIS) to 21MT-1 (IMC). This system thus reveals potential therapeutic targets and will provide a means of testing the influences of identified genes on transitions between these stages of pre-malignant to malignant growth.</p>

	]]>
</description>

<author>Lesley H. Souter et al.</author>


</item>






<item>
<title>Antioxidant Protection from HIV-1 gp120-induced Neuroglial Toxicity</title>
<link>http://ir.lib.uwo.ca/patholpub/5</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/patholpub/5</guid>
<pubDate>Sun, 11 Oct 2009 19:45:01 PDT</pubDate>
<description>
	<![CDATA[
	<p>Background: The pathogenesis of HIV-1 glycoprotein 120 (gp120) associated neuroglial toxicity remains unresolved, but oxidative injury has been widely implicated as a contributing factor. In previous studies, exposure of primary human central nervous system tissue cultures to gp120 led to a simplification of neuronal dendritic elements as well as astrocytic hypertrophy and hyperplasia; neuropathological features of HIV-1-associated dementia. Gp120 and proinflammatory cytokines upregulate inducible nitric oxide synthase (iNOS), an important source of nitric oxide (NO) and nitrosative stress. Because ascorbate scavenges reactive nitrogen and oxygen species, we studied the effect of ascorbate supplementation on iNOS expression as well as the neuronal and glial structural changes associated with gp120 exposure.</p>
<p>Methods: Human CNS cultures were derived from 16-18 week gestation post-mortem fetal brain. Cultures were incubated with 400 microM ascorbate-2-O-phosphate (Asc-p) or vehicle for 18 hours then exposed to 1 nM gp120 for 24 hours. The expression of iNOS and neuronal (MAP2) and astrocytic (GFAP) structural proteins was examined by immunohistochemistry and immunofluorescence using confocal scanning laser microscopy (CSLM).</p>
<p>Results: Following gp120 exposure iNOS was markedly upregulated from undetectable levels at baseline. Double label CSLM studies revealed astrocytes to be the prime source of iNOS with rare neurons expressing iNOS. This upregulation was attenuated by the preincubation with Asc-p, which raised the intracellular concentration of ascorbate. Astrocytic hypertrophy and neuronal injury caused by gp120 were also prevented by preincubation with ascorbate.</p>
<p>Conclusions: Ascorbate supplementation prevents the deleterious upregulation of iNOS and associated neuronal and astrocytic protein expression and structural changes caused by gp120 in human brain cell cultures.</p>

	]]>
</description>

<author>Kimberley A. Walsh et al.</author>


</item>






<item>
<title>Primary PEComa of the Bladder Treated with Primary Excision and Adjuvant Interferon-alpha Immunotherapy: A Case Report</title>
<link>http://ir.lib.uwo.ca/patholpub/4</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/patholpub/4</guid>
<pubDate>Wed, 23 Sep 2009 15:43:18 PDT</pubDate>
<description>
	<![CDATA[
	<p>Background: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms of uncertain malignant potential, which have in common the co-expression of muscle and melanocytic immunohistochemical markers.</p>
<p>Case presentation: A 48-year-old man presented with dysuria, passage of urinary sediment and lower abdominal discomfort. A three centimeter mass was identified by cystoscopy in the posterior midline of the bladder. Computerized tomography suggested an enterovesical fistula. The patient underwent laparotomy, partial cystectomy and partial small bowel resection. Pathological examination revealed PEComa of the bladder. The patient underwent adjuvant interferon-α immunotherapy. Subsequent follow-up procedures, including cystoscopy and imaging, have not revealed evidence of recurrence. The patient is clinically free of disease 48 months after surgery.</p>
<p>Conclusion: This case represents the second documented PEComa of bladder and demonstrates that adjuvant therapies, including anti-angiogenic and immunotherapy, may be considered for patients with locally advanced or metastatic genitourinary PEComa.</p>

	]]>
</description>

<author>Jeremy R. Parfitt et al.</author>


</item>






<item>
<title>In-situ and Invasive Carcinoma within a Phyllodes Tumor Associated with Lymph Node Metastases</title>
<link>http://ir.lib.uwo.ca/patholpub/3</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/patholpub/3</guid>
<pubDate>Wed, 23 Sep 2009 15:35:32 PDT</pubDate>
<description>
	<![CDATA[
	<p>Background: Phyllodes tumors (cystosarcoma phyllodes) are uncommon lesions in the female breast. Rarely, the occurrence of carcinoma within a phyllodes tumor has been reported in the literature, but has never been associated with lymph node metastases.</p>
<p>Case Presentation: A 26-year-old woman presented with a firm, mobile, non-tender mass in the left breast and palpable lymph nodes in the left axilla. The excised lesion appeared well circumscribed and lobulated, with variable fleshy and firm areas. Microscopic examination showed a circumscribed fibroepithelial lesion with a well developed leaf-like architecture, in keeping with a benign phyllodes tumor. The epithelial component showed extensive high grade ductal carcinoma in-situ (DCIS) and invasive carcinoma of no special type, located entirely within the phyllodes tumor. Subsequent axillary lymph node dissection revealed metastatic carcinoma in four lymph nodes.</p>
<p>Conclusions: Although rare, phyllodes tumors may harbor DCIS and invasive carcinoma, with potential for lymph node metastasis.</p>

	]]>
</description>

<author>Jeremy R. Parfitt et al.</author>


</item>






<item>
<title>Human CNS Cultures Exposed to HIV-1 gp120 Reproduce Dendritic Injuries of HIV-1-associated Dementia</title>
<link>http://ir.lib.uwo.ca/patholpub/2</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/patholpub/2</guid>
<pubDate>Thu, 17 Sep 2009 17:34:17 PDT</pubDate>
<description>
	<![CDATA[
	<p>HIV-1-associated dementia remains a common subacute to chronic central nervous system degeneration in adult and pediatric HIV-1 infected populations. A number of viral and host factors have been implicated including the HIV-1 120 kDa envelope glycoprotein (gp120). In human post-mortem studies using confocal scanning laser microscopy for microtubule-associated protein 2 and synaptophysin, neuronal dendritic pathology correlated with dementia. In the present study, primary human CNS cultures exposed to HIV-1 gp120 at 4 weeks in vitro suffered gliosis and dendritic damage analogous to that described in association with HIV-1-associated dementia.</p>

	]]>
</description>

<author>Sam Iskander et al.</author>


</item>






<item>
<title>Differential Effects of Curcumin on Vasoactive Factors in the Diabetic Rat Heart</title>
<link>http://ir.lib.uwo.ca/patholpub/1</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/patholpub/1</guid>
<pubDate>Tue, 18 Aug 2009 17:02:39 PDT</pubDate>
<description>
	<![CDATA[
	<p>Background: Increased oxidative stress has been associated with the pathogenesis of chronic diabetic complications, including cardiomyopathy. Recent studies indicate that curcumin, a potent antioxidant, may be beneficial in preventing diabetes-induced oxidative stress and subsequent secondary complications. We have investigated the effects of curcumin on the nitric oxide (NO) pathway in cardiac tissues and cultured cells.</p>
<p>Methods: Streptozotocin-induced diabetic rats were treated with curcumin for a period of one month. Heart tissues were then analyzed for endothelial NO synthase (eNOS) and inducible NO synthase (iNOS) mRNA expression. Oxidative protein and DNA damage were assessed by immunohistochemical analysis of nitrotyrosine and 8-hydroxy-2'-deoxyguanosine (8-OHdG). Heart tissues were further subjected to endothelin-1 (ET-1) mRNA expression. In order to further characterize the effects of curcumin, we assayed microvascular endothelial cells (MVECs). Cultured MVECs, exposed either to glucose or glucose and varying concentrations of curcumin, were assessed for alterations of NOS expression and activation of nuclear factor-kappaB (NF-kappaB) and activating protein-1 (AP-1). Oxidative stress and ET-1 expression levels were also assayed.</p>
<p>Results: Our results indicate that one month of diabetes causes an upregulation of both eNOS and iNOS mRNA levels, and nitrotyrosine and 8-OHdG immunoreactivity in the heart. Treatment of diabetic rats with curcumin reduced eNOS and iNOS levels in association with reduced oxidative DNA and protein damage. Interestingly, curcumin further increased vasoconstrictor ET-1 in the heart. Exposure of MVECs to high glucose increased both eNOS and iNOS levels and oxidative stress. Curcumin prevented NOS alteration and oxidative stress in a dose-dependent manner which was mediated by nuclear factor-kappaB and activating protein-1. Exposure to curcumin also increased ET-1 levels in the MVECs.</p>
<p>Conclusion: Our studies indicate the differential effects of curcumin in vasoactive factor expression in the heart and indicate the importance of tissue microenvironment in the treatment of diabetic complications.</p>

	]]>
</description>

<author>Hana Farhangkhoee et al.</author>


</item>





</channel>
</rss>
